Related Experiment Video

Updated: Jul 9, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Universal tumor antigens for cancer vaccination: targeting telomerase for immunoprevention

Robert H Vonderheide1

  • 1Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. rhv@mail.med.upenn.edu

Discovery Medicine
|December 21, 2007
PubMed

Insights

Therapeutic cancer vaccines face challenges, but targeting telomerase reverse transcriptase (hTERT) shows promise. Clinical trials indicate hTERT vaccination can safely induce immune responses, potentially preventing cancer recurrence or development.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Therapeutic cancer vaccines have not met regulatory approval despite significant potential.
  • Vaccination against infectious pathogens is highly successful, with some vaccines preventing cancer.
  • Current cancer vaccine strategies targeting non-viral antigens require re-evaluation.

Purpose of the Study:

  • To explore novel universal tumor antigens for cancer vaccines.
  • To investigate the potential of telomerase reverse transcriptase (hTERT) as a cancer vaccine target.
  • To assess the safety and efficacy of hTERT-specific immune responses in clinical trials.

Main Methods:

  • Immunological analysis to identify widely applicable tumor antigens.
  • Clinical trials to evaluate the induction of hTERT-specific immune responses.
  • Assessment of safety and toxicity of hTERT vaccination.

Main Results:

  • Telomerase reverse transcriptase (hTERT) is identified as a promising universal tumor antigen recognized by T lymphocytes.
  • Initial clinical trials demonstrate that hTERT-specific immune responses can be safely induced in cancer patients.
  • The induction of cellular immunity against hTERT without toxicity is achievable.

Conclusions:

  • hTERT represents a novel class of universal tumor antigens with broad applicability.
  • Safe induction of hTERT-specific immunity in cancer patients offers a new therapeutic avenue.
  • Optimizing hTERT vaccination could reduce cancer recurrence and potentially prevent cancer development.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...